{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "VCNX",
    "data": {
        "bs": [
            {
                "label": "TOTAL LIABILITIES",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 6849000
            },
            {
                "label": "Common stock, par value of $0.0001 per share; 100,000,000 shares authorized as of June 30, 2021, and December 31, 2020; 30,801,962 and 22,388,027 shares issued as of June 30, 2021 and December 31, 2020, respectively; 30,801,110 and 22,387,175 shares outstanding as of June 30, 2021 and December 31, 2020, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 3000
            },
            {
                "label": "Commitments and contingencies (Note 7)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -290024000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -290000000.0
            },
            {
                "label": "Treasury stock, at cost; 852 shares of common stock as of June 30, 2021 and December 31, 2020, respectively",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 11000
            },
            {
                "label": "TOTAL STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 16940000
            },
            {
                "label": "TOTAL STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 16940000
            },
            {
                "label": "Total Vaccinex, Inc. stockholders\u2019 equity (deficit)",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 16940000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 22385000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 347000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 347000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 306972000
            },
            {
                "label": "TOTAL ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 23789000
            },
            {
                "label": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 23789000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 23442000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1721000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1505000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1505000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1057000
            },
            {
                "label": "Long-term debt",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 1134000
            },
            {
                "label": "Senior secured convertible debt, net",
                "concept": "ConvertibleDebt",
                "unit": "usd",
                "value": 2489000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 5715000
            }
        ],
        "cf": [
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 232000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -22000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 91000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 91000
            },
            {
                "label": "Debt related charges included in interest expense",
                "concept": "InterestExpenseDebt",
                "unit": "usd",
                "value": 371000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -14096000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -14100000.0
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": -432000
            },
            {
                "label": "Purchase of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 22000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 524000
            },
            {
                "label": "Proceeds from issuance of common stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 32848000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 25907000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -1448000
            },
            {
                "label": "Payments of common stock issuance costs",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 985000
            },
            {
                "label": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 11789000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -157000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -12543000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -12543000
            },
            {
                "label": "Redemption of convertible debt",
                "concept": "vcnx:RedemptionOfConvertibleDebt",
                "unit": "usd",
                "value": 5956000
            }
        ],
        "ic": [
            {
                "label": "Net loss per share attributable to Vaccinex, Inc. common stockholders, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.47
            },
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 850000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -12543000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -11909000
            },
            {
                "label": "Weighted-average shares used in computing net loss per share attributable to Vaccinex, Inc. common stockholders, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 26897283
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 49000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 3182000
            },
            {
                "label": "Net loss attributable to noncontrolling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 683000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 9577000
            },
            {
                "label": "Net loss attributable to Vaccinex, Inc. common stockholders",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -12543000
            },
            {
                "label": "Total costs and expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 12759000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -12543000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -12543000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -12543000
            }
        ]
    }
}